Freund Natalia

Medicine & Life Sciences

1. Antibodies 100%
2. Broadly Neutralizing Antibodies 96%
3. HIV-1 80%
4. Epitopes 78%
5. SARS Virus 59%
6. B-Lymphocytes 56%
7. Neutralizing Antibodies 50%
8. Vaccines 39%
9. Polysaccharides 38%
10. B-Lymphocyte Epitopes 38%
11. Epitope Mapping 30%
12. Peptides 28%
13. HIV Antibodies 27%
14. Coronavirus 25%
15. Peptide Library 25%
16. Severe Acute Respiratory Syndrome 23%
17. Immunization 22%
18. Bacteriophages 20%
19. Infections 18%
20. Monoclonal Antibodies 17%
21. Antigens 16%
22. Immunoglobulin lambda-Chains 15%
23. Monkeypox 15%
24. Monkeypox virus 15%
25. Coronavirus Spike Glycoproteins 15%
26. Immunoglobulin G 15%
27. Proteins 15%
28. Glycoproteins 14%
29. AIDS Vaccines 14%
30. Binding Sites 14%
31. angiotensin converting enzyme 2 13%
32. Complementarity Determining Regions 12%
33. Neoplasm Antibodies 12%
34. Immunoglobulin Light Chains 12%
35. Interleukin-33 12%
36. Antibody Formation 11%
37. Immunity 11%
38. Mycobacterium tuberculosis 11%
39. Messenger RNA 11%
40. B-Lymphoid Precursor Cells 11%
41. Microfluidics 11%
42. Seroconversion 10%
43. Mycobacterium 10%
44. Viruses 9%
45. Allergy and Immunology 9%
46. Vaccination 9%
47. Tuberculosis 9%
48. Tissue Donors 9%
49. Adrenergic Agents 9%
50. Adrenergic Receptors 8%